Related Experiment Videos
Therapeutic range in transscleral contact cyclophotocoagulation
1Universitäts-Augenklinik, Mainz, Germany.
Summary
This study explored optimal parameters for Nd:YAG laser contact cyclophotocoagulation (CP) in porcine eyes. Results indicate shorter exposure times are crucial for effective ciliary body treatment while minimizing damage.
Area of Science:
- Ophthalmology
- Medical Devices
- Laser Technology
Background:
- Contact cyclophotocoagulation (CP) is a preferred glaucoma treatment over noncontact methods due to reduced ocular surface damage.
- Optimal laser parameters for contact CP, including wavelength and protocol, require further definition.
Purpose of the Study:
- To investigate the effects of varying power levels and exposure durations of a continuous-wave Nd:YAG laser on porcine ciliary bodies.
- To establish the therapeutic range and identify potential damaging effects of laser contact cyclophotocoagulation.
Main Methods:
- Utilized a 1064 nm continuous-wave Nd:YAG laser with a bare fiber on 30 enucleated porcine eyes.
- Applied laser treatments at varying power (1.0-10.0 W) and exposure durations (0.5-4.0 s) with controlled intraocular pressure.
- Defined treatment effects based on ciliary body whitening and structural integrity, noting 'pop' effects indicating supramaximal damage.
Main Results:
- Shorter exposure durations (0.5 s) showed a wider therapeutic range compared to longer durations.
- Increasing exposure time significantly reduced the power required for therapeutic effects, narrowing the safety margin.
- Supramaximal 'pop' effects, characterized by rapid tissue destruction, were observed at higher power levels or longer exposures.
Conclusions:
- A 0.5-second exposure duration appears to offer the most favorable therapeutic window for Nd:YAG laser contact cyclophotocoagulation.
- Careful control of laser power and exposure time is essential to achieve desired ciliary body effects while avoiding destructive 'pop' effects.
- Further research is needed to translate these findings into optimized clinical protocols for glaucoma management.